These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15908015)

  • 1. Increased serum neopterin levels in adults with Down syndrome.
    Mehta PD; Patrick BA; Dalton AJ; Patel B; Mehta SP; Pirttila T; Coyle PK
    J Neuroimmunol; 2005 Jul; 164(1-2):129-33. PubMed ID: 15908015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome.
    Prasher VP; Airuehia E; Patel A; Haque MS
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):937-42. PubMed ID: 18395888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotype and mental retardation in Down syndrome.
    Cavani S; Tamaoka A; Moretti A; Marinelli L; Angelini G; Di Stefano S; Piombo G; Cazzulo V; Matsuno S; Shoji S; Furiya Y; Zaccheo D; Dagna-Bricarelli F; Tabaton M; Mori H
    Am J Med Genet; 2000 Nov; 95(3):224-8. PubMed ID: 11102927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.
    Fukumoto H; Tennis M; Locascio JJ; Hyman BT; Growdon JH; Irizarry MC
    Arch Neurol; 2003 Jul; 60(7):958-64. PubMed ID: 12873852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
    Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta concentrations in older people with Down syndrome and dementia.
    Jones EL; Hanney M; Francis PT; Ballard CG
    Neurosci Lett; 2009 Feb; 451(2):162-4. PubMed ID: 19111900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased soluble APPalpha, Abeta 1-42, and anti-Abeta 1-42 antibodies in plasma from down syndrome patients.
    Conti E; Galimberti G; Piazza F; Raggi ME; Ferrarese C
    Alzheimer Dis Assoc Disord; 2010; 24(1):96-100. PubMed ID: 19571731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects.
    Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A
    J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
    Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
    Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid beta protein in young and elderly depression: a pilot study.
    Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
    Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Rabbit Monoclonal Antibody to Amyloid-β38 (Aβ38): Increased Plasma Aβ38 Levels in Down Syndrome.
    Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Miller DL
    J Alzheimers Dis; 2015; 46(4):1021-32. PubMed ID: 26402629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronal Abeta42 accumulation in Down syndrome brain.
    Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
    Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid beta protein 1-42 levels are increased in old Down Syndrome but not in young Down Syndrome.
    Mehta PD; Mehta SP; Fedor B; Patrick BA; Emmerling M; Dalton AJ
    Neurosci Lett; 2003 May; 342(3):155-8. PubMed ID: 12757888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome.
    Tokuda T; Fukushima T; Ikeda S; Sekijima Y; Shoji S; Yanagisawa N; Tamaoka A
    Ann Neurol; 1997 Feb; 41(2):271-3. PubMed ID: 9029078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
    Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
    Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.